Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
We read with interest the editorial concerning the use of subcutaneous furosemide in heart failure. We feel that there is substantial opportunity for misinterpretation of the editorial by readers not as familiar with the issues raised as the eminent authors themselves.
This particularly relates to:
Heart failure syndrome
It is important to emphasise that the editorial relates to the treatment of congestive symptoms in patients with the heart failure syndrome irrespective of its causal mechanism, that is, left ventricular systolic dysfunction is only one of the many mechanisms inducing this syndrome. This means that 50% of patients hospitalised with heart failure do not have left ventricular systolic dysfunction.1 2
The use of furosemide in heart failure symptom relief
It is important to recognise that the lack of evidence suggested for subcutaneous furosemide is equally applicable to any route of delivery for …
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.